- Home
- AVIR vs GCGR Comparison
AVIR vs GCGR Comparison
Compare AVIR & GCGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.43
Company Overview
Basic Information| Metric | AVIR | GCGR |
|---|---|---|
| Founded | 2012 | 2026 |
| Country | United States | United States |
| Employees | 55 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 334.5M | 467.9M |
| IPO Year | 2020 | 2026 |
Fundamental Metrics
Financial Performance| Metric | AVIR | GCGR |
|---|---|---|
| Price | $4.43 | $10.04 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 283.2K | 112.1K |
| Earning Date | 11-09-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $351,367,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.87 | $9.95 |
| 52 Week High | $6.45 | $10.20 |
Technical Indicators
Market Signals| Indicator | AVIR | GCGR |
|---|---|---|
| Relative Strength Index (RSI) | 35.94 | 53.07 |
| Support Level | $4.06 | $10.09 |
| Resistance Level | $4.69 | $10.17 |
| Average True Range (ATR) | 0.26 | 0.03 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 27.43 | 78.95 |
Price Performance
Historical Comparison AVIR
GCGR
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About GCGR General Catalyst Global Resilience Merger Corp. Class A Ordinary Shares
General Catalyst Global Resilience Merger Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.